4100.  Within 30 days after changing his or her address of record
with the board or after changing his or her name according to law,
every pharmacist, intern pharmacist, technician, or exemptee shall
notify the executive officer of the board of the change of address or
change of name.



4101.  (a) Any pharmacist who takes charge of, or acts as
pharmacist-in-charge of a pharmacy or other entity licensed by the
board, who terminates his or her employment at the pharmacy or other
entity, shall notify the board within 30 days of the termination of
employment.
   (b) Any exemptee who takes charge of, or acts as manager of, a
wholesaler or veterinary food-drug animal retailer, who terminates
his or her employment at that entity shall notify the board within 30
days of the termination of employment.
   (c) This section shall become operative on July 1, 2001.




4103.  Notwithstanding Section 2038, or any other provision of law,
a pharmacist may take a person's blood pressure and may inform the
person of the results, render an opinion as to whether the reading is
within a high, low, or normal range, and may advise the person to
consult a physician of the person's choice.  Pharmacists rendering
this service shall utilize commonly accepted community standards in
rendering opinions and referring patients to physicians.  Enforcement
of this section is vested in the Board of Pharmacy of the State of
California.  Any pharmacist who performs this service shall not be in
violation of Section 2052.



4104.  (a) Pharmacies shall have in place procedures for taking
action to protect the public when a licensed individual employed by
or with the pharmacy is known to be chemically, mentally, or
physically impaired to the extent it affects his or her ability to
practice the profession or occupation authorized by his or her
license.
   (b) Pharmacies shall have in place procedures for taking action to
protect the public when a licensed individual employed by or with
the pharmacy is known to have engaged in the theft or diversion or
self-use of prescription drugs belonging to the pharmacy.
   (c) The board may, by regulation, establish requirements for
reporting to the board conduct or incidents described in subdivision
(a) or (b).



4105.  (a) All records or other documentation of the acquisition and
disposition of dangerous drugs and dangerous devices by any entity
licensed by the board shall be retained on the licensed premises in a
readily retrievable form.
   (b) The licensee may remove the original records or documentation
from the licensed premises on a temporary basis for license-related
purposes.  However, a duplicate set of those records or other
documentation shall be retained on the licensed premises.
   (c) The records required by this section shall be retained on the
licensed premises for a period of three years from the date of
making.
   (d) Any records that are maintained electronically shall be
maintained so that the pharmacist-in-charge, the pharmacist on duty
if the pharmacist-in-charge is not on duty, or, in the case of a
veterinary food-animal drug retailer or wholesaler, the exemptee,
shall, at all times during which the licensed premises are open for
business, be able to produce a hard copy and electronic copy of all
records of acquisition or disposition or other drug or
dispensing-related records maintained electronically.
   (e) (1) Notwithstanding subdivisions (a), (b), and (c), the board,
may upon written request, grant to a licensee a waiver of the
requirements that the records described in subdivisions (a), (b), and
(c) be kept on the licensed premises.
   (2) A waiver granted pursuant to this subdivision shall not affect
the board's authority under this section or any other provision of
this chapter.
   (f) This section shall become operative on July 1, 2001.